The US Patent & Trademark office shows that the number of AIA petitions filed in FY 2015 is more than 75 times higher than the number of CMBs and IPRs that were initiated in 2012. Moreover, after four years of operation, now is the perfect time to analyze trends and developments in the PTAB trials. It is also a good opportunity to discuss the rise in settlements, the impact of new rule changes, and the relationship with the Federal Circuit and District Courts.
In addition to Morgan Lewis being a proud sponsor of the event, our IP partner Richard de Bodo will moderate, and IP partner Robert Smyth will be a panelist for "Pharma & THE PTAB."
This panel will address topics including: